NNC 05-2090 hydrochloride, with the CAS number 184845-18-9, is a chemical compound that belongs to a class of substances known as peptide-based drugs. It is primarily recognized for its role as a selective agonist of the glucagon-like peptide-1 (GLP-1) receptor, which is significant in the regulation of glucose metabolism and insulin secretion. This compound is often studied for its potential therapeutic applications in the treatment of type 2 diabetes and obesity, as it can enhance insulin sensitivity and promote weight loss. In terms of its physical properties, NNC 05-2090 hydrochloride is typically characterized by its solubility in water, which facilitates its use in biological systems. The hydrochloride form indicates that it is a salt, which can enhance its stability and bioavailability. As with many pharmacological agents, its safety profile, efficacy, and mechanism of action are subjects of ongoing research, making it a compound of interest in medicinal chemistry and pharmacology.

NNC 05-2090 hydrochloride

184845-18-9: NNC 05-2090 hydrochloride, with the CAS number 184845-18-9, is a chemical compound that belongs to a class of substances known as peptide-based drugs. It is primarily recognized for its role as a selective agonist of the glucagon-like peptide-1 (GLP-1) receptor, which is significant in the regulation of glucose metabolism and insulin secretion. This compound is often studied for its potential therapeutic applications in the treatment of type 2 diabetes and obesity, as it can enhance insulin sensitivity and promote weight loss. In terms of its physical properties, NNC 05-2090 hydrochloride is typically characterized by its solubility in water, which facilitates its use in biological systems. The hydrochloride form indicates that it is a salt, which can enhance its stability and bioavailability. As with many pharmacological agents, its safety profile, efficacy, and mechanism of action are subjects of ongoing research, making it a compound of interest in medicinal chemistry and pharmacology.

<p>NNC 05-2090 HCl: BGT-1 inhibitor, IC50 = 10.6 μM, potential for epilepsy, neurological research.</p>

CAS 184845-18-9

NNC 05-2090 hydrochloride

NNC 05-2090 hydrochloride

Ref: 54-BUP01147

NNC 05-2090 hydrochloride

Ref: TM-T23072